Burden of neonatal infection Despite a substantial decline in childhood mortality rates in South Africa (SA) [1] and globally, [2] progress in neonatal mortality reduction has been much slower. Severe bacterial infections remain a leading cause of neonatal morbidity and mortality in sub-Saharan Africa, affecting nearly 1 million neonates and causing 250 000 deaths annually. [2] At the current rate of decline the United Nations Sustainable Development Goal of reducing neonatal mortality rates to ˂12 deaths per 1 000 live births by 2030, will not be attained by many African countries. [3] In SA, infections were estimated to cause 13.1% of neonatal deaths among babies >1 kg from 2012 to 2016 (Perinatal Problem Identification Programme (PPIP) data). [1] However, recent postmortem minimally invasive tissue sampling (MITS) data from the largest neonatal unit in SA (Chris Hani Baragwanath Academic Hospital, Johannesburg) demonstrate that hospitalacquired, antimicrobial-resistant infections are now the leading cause of late neonatal mortality (after the first week of life). These hospital-acquired infections (HAIs) and infection-attributable deaths disproportionately affect preterm and low-birthweight neonates, and are responsible for 58% of deaths overall v. 70% of deaths in preterm infants. [4] Attributing cause of death with certainty, particularly in preterm infants, is difficult, and may lead to substantial underestimation of the true burden and impact of neonatal infection in SA. Challenges in diagnosis and surveillance of neonatal infection Major challenges in diagnosing severe neonatal bacterial infections persist. These include the nonspecific clinical presentation of sepsis, inequitable access to microbiology laboratory services, high blood culture contamination rates and low pathogen yields from submitted specimens. Importantly, blood culture, the current gold standard for confirming bacteraemia, has a sensitivity of ~30%, much lower than molecular testing or postmortem MITS. The lack of validated clinical This open-access article is distributed under Creative Commons licence CC-BY-NC 4.0.